An ERAP1 risk haplotype may increase the production of an autoantigenic peptide, leading to its presentation by HLA-C*06:02 and the activation of CD8+ T cell, which triggers autoimmune disease (56). This evidence concerns the gene HLA-C and autoimmune disease.